Drug Trial Radar · NCT06233799
Trial of Naltrexone/Bupropion for the Treatment of Methamphetamine Use Disorder
Last checked: Nov 19, 2026Latest source record: Jul 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
360
Planned (sponsor's estimate)
Start
Jul 1, 2024
Primary completion
Oct 30, 2026
Study completion Apr 30, 2027
Sponsor
- Lead sponsor
- National Institute on Drug Abuse (NIDA)NIH
- Sponsor type
- NIH
- First posted
- Jan 31, 2024
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective of this study is to evaluate the efficacy of extended release naltrexone plus bupropion XL (XR-NTX/BUP-XL) compared to matched injectable and oral placebo (iPLB/oPLB) in reducing methamphetamine (MA) use in individuals with moderate or severe methamphetamine use disorder (MUD) seeking to stop or reduce MA use.
Conditions
- Methamphetamine-dependence
- Methamphetamine Abuse
Interventions
extended-release naltrexone (XR-NTX)Drug
Once per three weeks injections of extended-release naltrexone
extended release bupropion (BUP-XL) tablets (BUP-XL)Drug
Daily oral extended release bupropion tablets
iPLBDrug
Once per three weeks injections of placebo
oPLBDrug
Daily oral placebo tablets
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants with at least 75% methamphetamine-negative urine drug screen tests during the evaluation period (i. e., Weeks 11-12)Time frame: 2 weeks (i. e., Weeks 11-12)
Locations
11 sites in 1 country. Site status is shown where the registry gives one.
University of Arkansas for Medical Sciences
Little Rock, Arkansas
University of California Los Angeles
Los Angeles, California
University of California at San Diego
San Diego, California
Indiana University
Indianapolis, Indiana
University of Kansas Medical Center
Kansas City, Kansas
University of Minnesota
Minneapolis, Minnesota
CODA
Portland, Oregon
MUSC/BHS
Pickens, South Carolina
University of Tennessee
Memphis, Tennessee
University of Texas Southwestern Medical Center
Dallas, Texas
University of Virginia
Charlottesville, Virginia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.